Comments on "Emerging insights and commentaries - MMRM vs LOCF by Naitee Ting"

J Biopharm Stat. 2024 Jan 2;34(1):146-148. doi: 10.1080/10543406.2023.2250853. Epub 2024 Jan 14.

Authors

David Wright¹, Daniel J Bratton², Thomas Drury², Oliver N Keene³, Sunita Rehal², Ian R White⁴

Affiliations

¹ Statistical Innovation, Data Science & Artificial Intelligence, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK.
² Statistics and Data Science Innovation Hub, GSK, London, UK.
³ KeeneONStatistics.
⁴ MRC Clinical Trials Unit at UCL, University College London.

PMID: 37747099
DOI: 10.1080/10543406.2023.2250853

No abstract available

MeSH terms

Data Interpretation, Statistical
Humans
Models, Statistical*
Tolnaftate*
Treatment Outcome

Substances

Tolnaftate

Grants and funding

MC_UU_00004/07/MRC_/Medical Research Council/United Kingdom